prostatic hyperplasia

Preferred Label : prostatic hyperplasia;

MeSH definition : Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.;

MeSH synonym : hyperplasia, prostatic;

Related MeSH term : prostatic hypertrophy; benign prostatic hyperplasia; prostatic hypertrophy, benign; adenoma, prostatic; Adenomas, Prostatic; Prostatic Adenomas; Prostatic Adenoma; Prostatic Hyperplasia, Benign; Benign Prostatic Hypertrophy; Hypertrophy, Benign Prostatic; Benign Prostatic Hyperplasias; Hyperplasia, Benign Prostatic; Hyperplasias, Benign Prostatic; Prostatic Hyperplasias, Benign; Hypertrophies, Prostatic; Hypertrophy, Prostatic; Prostatic Hypertrophies;

MeSH annotation : note category: non-neoplastic despite X refs ADENOMA, PROSTATIC & PROSTATIC ADENOMA; note category: non-neoplastic despite entry terms ADENOMA, PROSTATIC, and PROSTATIC ADENOMA;

Wikipedia link : https://en.wikipedia.org/wiki/Benign prostatic hyperplasia;

Details

Origin ID

D011470;

UMLS CUI

C2937421;

ATC code(s)
- Prunus africanae cortex [ATC Code]
- Sabalis serrulatae fructus [ATC Code]
ATC code(s)
- Prunus africanae cortex [ATC Code]
- Sabalis serrulatae fructus [ATC Code]
- alfuzosin [ATC Code]
- alfuzosin and finasteride [ATC Code]
- drugs used in benign prostatic hypertrophy [ATC Code]
- dutasteride [ATC Code]
- finasteride [ATC Code]
- mepartricin [ATC Code]
- silodosin [ATC Code]
- tamsulosin [ATC Code]
- tamsulosin and dutasteride [ATC Code]
- terazosin [ATC Code]
- testosterone-5-alpha reductase inhibitors [ATC Code]
Allowable qualifiers
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemically induced [MeSH Qualifier]
- classification [MeSH Qualifier]
- complications [MeSH Qualifier]
- congenital [MeSH Qualifier]
- diagnosis [MeSH Qualifier]
- diagnostic imaging [MeSH Qualifier]
- diet therapy [MeSH Qualifier]
- drug therapy [MeSH Qualifier]
- economics [MeSH Qualifier]
- embryology [MeSH Qualifier]
- enzymology [MeSH Qualifier]
- epidemiology [MeSH Qualifier]
- ethnology [MeSH Qualifier]
- etiology [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- microbiology [MeSH Qualifier]
- mortality [MeSH Qualifier]
- nursing [MeSH Qualifier]
- parasitology [MeSH Qualifier]
- pathology [MeSH Qualifier]
- physiopathology [MeSH Qualifier]
- prevention and control [MeSH Qualifier]
- psychology [MeSH Qualifier]
- radiotherapy [MeSH Qualifier]
- rehabilitation [MeSH Qualifier]
- surgery [MeSH Qualifier]
- therapy [MeSH Qualifier]
- urine [MeSH Qualifier]
- veterinary [MeSH Qualifier]
- virology [MeSH Qualifier]
CISMeF manual mappings
- benign prostatic hypertrophy [ICPC-2 Rubric]
Currated CISMeF NLP mapping
- Benign Prostatic Hyperplasia [NCIt concept]
- Benign adenoma of prostate (disorder) [SNOMED CT concept]
- Benign prostatic hyperplasia [PASCAL descriptor]
- Benign prostatic hyperplasia [ICD-10 category]
- Benign prostatic hyperplasia [HPO term]
- Benign prostatic hyperplasia [MedDRA Preferred Term]
- Benign prostatic hyperplasia (disorder) [SNOMED CT concept]
- Benign prostatic hypertrophy [MedDRA LLT]
- Hyperplasia of prostate [ICD-11 Category]
- Hyperplasia of prostate [ICD-10 category (who)]
- Hyperplasia of prostate [MedDRA LLT]
- Hyperplasia of prostate (disorder) [SNOMED CT concept]
- Hyperplasia of the prostate [MedDRA LLT]
- Prostate Adenoma [LOINC System]
- Prostate Adenoma [NCIt concept]
- Prostate adenoma [MedDRA LLT]
- Prostatic adenoma [MedDRA Preferred Term]
- Prostatic hyperplasia [MedDRA LLT]
- Prostatic hyperplasia, benign [OMIM Phenotype]
- Prostatic hypertrophy (benign) [MedDRA LLT]
- benign adenoma of prostate [SNOMED Notion]
- benign prostatic hyperplasia [Radlex concept]
- hyperplasia of prostate, nos [SNOMED Notion]
- prostate hyperplasia [Disease (Nov.)]
- prostatic adenoma [DO Concept]
DO Cross reference
- prostatic adenoma [DO Concept]
HPO term
- Benign prostatic hyperplasia [HPO term]
Indexing information
- 4-(1-methyl-2-oxopiperid-5-yl)benzoate [MeSH Supplementary Concept]
- BPH-associated protein P25-26 [MeSH Supplementary Concept]
- Prosta-Capsules [MeSH Supplementary Concept]
- Prostamol-Uno [MeSH Supplementary Concept]
- alfuzosin [MeSH Supplementary Concept]
- bazoton [MeSH Supplementary Concept]
- paraprost [MeSH Supplementary Concept]
- prostamed [MeSH Supplementary Concept]
- robaveron [MeSH Supplementary Concept]
- saw palmetto extract [MeSH Supplementary Concept]
MedlinePlus topic(s)
- prostate diseases [MedlinePlus Topic]
Record concept(s)
- adenoma, prostatic [MeSH concept]
- benign prostatic hyperplasia [MeSH concept]
- prostatic hyperplasia [MeSH concept]
- prostatic hypertrophy [MeSH concept]
Related MeSH Supplementary Concept(s)
- prostatic stromal proliferation of uncertain malignant potential [MeSH Supplementary Concept]
See also
- prostatic neoplasms [MeSH Descriptor]
- prostatism [MeSH Descriptor]
See also (suggested by CISMeF)
- ultrasound, High-Intensity focused, transrectal [MeSH Descriptor]
See also inter- (CISMeF)
- prostate adenoma [Disease (Nov.)]
Semantic type(s)
- Pathologic Function [UMLS semantic type]
UMLS correspondences (same concept)
- Hyperplasia of prostate [ICD-9 code]
- Hyperplasia of prostate [MedDRA LLT]
- Hyperplasia of prostate [ICD-10 category (who)]
- Hyperplasia of prostate (disorder) [SNOMED CT concept]
- Hyperplasia of prostate, unspecified [ICD-9 code]
- Hyperplasia of the prostate [MedDRA LLT]
- Prostatic hyperplasia [MedDRA LLT]
- hyperplasia of prostate, nos [SNOMED Notion]
Validated automatic mappings to BTNT
- benign prostatic hyperplasia [Disease (Nov.)]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients